Evaluation of fruquintinib, a potent and selective oral VEGFR inhibitor, in combination with targeted therapies or immune checkpoint inhibitors in preclinical tumor models
- Resource Type
- Journal
- Source
CANCER RESEARCH ; JUL 2017, 77 2p. Supplement: 13- Subject
- Language
- English
- ISSN
- 15387445